Article metrics

Download PDFPDF

Original research
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension

 

Online download statistics by month:

Online download statistics by month: September 2021 to September 2021

AbstractFullPdf
Sep 2021300293243
Total300293243